BlackRock Japan’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

BlackRock Japan’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$19K	Buy	2,421 +1,971	+438%	+$18.1K	﹤0.01%	1141
2016 Q3	$5K	Buy	+450	New	+$5.24K	﹤0.01%	1263
2014 Q1	–	Sell	-5,393	Closed	-$159K	–	1554
2013 Q4	$159K	Sell	5,393 -38	-0.7%	-$696	﹤0.01%	950
2013 Q3	$83K	Buy	+5,431	New	+$101K	﹤0.01%	1033

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock Japan's OMED Position: Q4 2016 in Review

BlackRock Japan increased its OncoMed Pharmaceuticals, Inc. (OMED) stake by 438% in Q4 2016, buying an estimated $18.1K and bringing the position to 2,421 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

BlackRock Japan first reported a position in OMED in Q3 2013 and has held it in 4 quarters since. The position peaked at $159K in Q4 2013. 86 funds tracked by Wall St. Rank hold OMED as of Q4 2016.

BlackRock Japan held 2,421 shares of OncoMed Pharmaceuticals, Inc. worth $19K as of Q4 2016.
BlackRock Japan bought 1,971 OncoMed Pharmaceuticals, Inc. shares in Q4 2016, an estimated $18.1K.
OncoMed Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1141 holding.
BlackRock Japan first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and has held it in 4 quarters since.
BlackRock Japan's OncoMed Pharmaceuticals, Inc. position peaked at $159K in Q4 2013.
86 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.